Artificial Intelligence in Healthcare Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	159 Pages	Fortune Business Insights Pvt. Ltd.	October, 2024	FOB19224232

Best Price Guarantee
Price	from $4,850
Length	159 Pages
Publisher	Fortune Business Insights Pvt. Ltd.
Published Date	October, 2024
SKU	FOB19224232

Artificial Intelligence in Healthcare Market

Growth Factors of Artificial Intelligence in Healthcare Market

The artificial intelligence in healthcare market size was valued at USD 19.54 billion in 2023, and the market is now projected to grow from USD 27.69 billion in 2024 to USD 490.96 billion by 2032, exhibiting a CAGR of 43.2% during the forecast period of 2023-2032.

The COVID-19 pandemic posed significant challenges on the artificial intelligence in healthcare market growth. Due to lack of industrial operations and a halt in commercial campaigns, implementation of government policies, investments in projects and other initiatives due to covid pandemic., which lead a decline in the artificial intelligence in healthcare market expansion. Lockdown enacted in numerous nations have hindered the manufacturing and caused transportation delays. In addition, worldwide restrictions have caused a halt in economic activities. Despite the challenges of covid pandemic, the battery plate sector has proven to be robust. Although the construction of electric vehicle has been delayed due to shortage of man power and procurement concerns of raw material.

Rising Investments by the private and public sectors in artificial intelligence to promote the artificial intelligence in healthcare market growth significantly. The majority of healthcare providers operating in the industry investing more and more in artificial intelligence owing to the technology's efficiency, speed, and lower costs fueling market expansion. Moreover, integration of artificial intelligence helps medical professionals detect diseases early on and improve patient outcomes. These are the key factors have led to an increase in investments by pharmaceutical and MedTech companies in AI to expand their businesses.

Growing use of robotics and artificial intelligence is revolutionizing the healthcare sector promoting market growth during forecast period. Artificial intelligence has been quickly changing the global healthcare sector in recent years. It has introduced previously unheard-of resources for patient care, diagnosis, and treatment. In response to this increasing demand, healthcare providers are concentrating on technological developments that improve the identification and management of a range of clinical indications. In addition, a number of tools, including virtual assistants, can be used to track patient health and give medication alerts, provide e-consultations, change patient symptom checks, and much more to enhance patient care.

Comprehensive Analysis of Artificial Intelligence in Healthcare Market

The artificial intelligence in healthcare market and healthcare industry is rising at an exponential rate due to its market segmentation. This market expansion effectively provides a detailed regional assessments considering the dominant supply and demand forces that impact the pharmacy benefit management industry. These segmentations are methodically segregated by platform, by application and by end users. The platform segmentation includes, Solutions and Services and by Application segmentation includes Robot-Assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Clinical Trials, Diagnostics, and Others. However, the end users segmentation includes Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Contract Research Organization (CRO), and Others.

The North America region lead the medical devices market by benefitting a market size of USD 8.78 billion in 2023 due to growing use of robotics and artificial intelligence in healthcare sector and rising investments in artificial intelligence by private and public sectors.

The prominent players in the market play an important role in the healthcare industry assuring industrial prospectus growth and setting market standards. These key players include, Siemens Healthineers AG (Germany), Hewlett Packard Enterprise Company (U.S.), NVIDIA Corporation (U.S.), Alphabet Inc. (U.S.), General Electric Company (U.S.) and UnitedHealth Group, (Optum Inc.) (U.S.) these market players provide a level-playing competitive environment across the globe.

In October 2023, Google introduced a novel generative AI tool designed to make it easier for medical professionals to locate precise and pertinent clinical information which will help to diagnose with efficacy.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 43.2% from 2024-2032

Unit Value (USD billion)

Segmentation By Platform

Solutions
Services

By Application

Robot-Assisted Surgery
Virtual Nursing Assistant
Administrative Workflow Assistance
Clinical Trials
Diagnostics
Others

By End-user

Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Contract Research Organization (CRO)
Others

By Region

North America (By Platform, Application, End-user, and Country)
U.S.
Canada
Europe (By Platform, Application, End-user, and Country/sub-region)
UK
Germany
France
Scandinavia
Rest of Europe
Asia Pacific (By Platform, Application, End-user, and Country/sub-region)
Japan
China
India
Southeast Asia
Rest of Asia Pacific
Latin America (By Platform, Application, End-user, and Country/sub-region)
Brazil
Mexico
Rest of Latin America
Middle East & Africa (By Platform, Application, End-user, and Country/sub-region)
GCC
South Africa
Rest of Middle East & Africa

Please Note: It will take 5-6 business days to complete the report upon order confirmation.

1. Introduction: 1.1. Research Scope; 1.2. Market Segmentation; 1.3. Research Methodology; 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics: 3.1. Market Drivers; 3.2. Market Restraints; 3.3. Market Opportunities; 3.4. Market Trends
4. Key Insights: 4.1. Technological Advancements Pertaining to the Artificial Intelligence in Healthcare; 4.2. Regulatory Scenario for Key Countries; 4.3. Overview on Application of AI in Hospitals and Clinics; 4.4. Challenges Faced During Adoption and Implementation of AI-based Solutions; 4.5. Key Performance Indicators for Artificial Intelligence in the Healthcare Market; 4.6. Key Industry Developments, Such as Partnerships, Mergers and Acquisitions; 4.7. Impact of COVID-19 on the Market
5. Global Artificial Intelligence in Healthcare Analysis, Insights and Forecast, 2019-2032: 5.1. Market Analysis, Insights and Forecast – By Platform; 5.1.1. Solutions; 5.1.2. Services; 5.2. Market Analysis, Insights and Forecast – By Application; 5.2.1. Robot-Assisted Surgery; 5.2.2. Virtual Nursing Assistant; 5.2.3. Administrative Workflow Assistance; 5.2.4. Clinical Trials; 5.2.5. Diagnostics; 5.2.6. Others; 5.3. Market Analysis, Insights and Forecast – By End-user; 5.3.1. Hospitals & Clinics; 5.3.2. Pharmaceutical & Biotechnology Companies; 5.3.3. Contract Research Organization (CRO); 5.3.4. Others; 5.4. Market Analysis, Insights and Forecast – By Geography; 5.4.1. North America; 5.4.2. Europe; 5.4.3. Asia Pacific; 5.4.4. Latin America; 5.4.5. Middle East & Africa
6. North America Artificial Intelligence in Healthcare Analysis, Insights and Forecast, 2019-2032: 6.1. Market Analysis, Insights and Forecast – By Platform; 6.1.1. Solutions; 6.1.2. Services; 6.2. Market Analysis, Insights and Forecast – By Application; 6.2.1. Robot-Assisted Surgery; 6.2.2. Virtual Nursing Assistant; 6.2.3. Administrative Workflow Assistance; 6.2.4. Clinical Trials; 6.2.5. Diagnostics; 6.2.6. Others; 6.3. Market Analysis, Insights and Forecast – By End-user; 6.3.1. Hospitals & Clinics; 6.3.2. Pharmaceutical & Biotechnology Companies; 6.3.3. Contract Research Organization (CRO); 6.3.4. Others; 6.4. Market Analysis, Insights and Forecast – By Country; 6.4.1. U.S.; 6.4.2. Canada
7. Europe Artificial Intelligence in Healthcare Analysis, Insights and Forecast, 2019-2032: 7.1. Market Analysis, Insights and Forecast – By Platform; 7.1.1. Solutions; 7.1.2. Services; 7.2. Market Analysis, Insights and Forecast – By Application; 7.2.1. Robot-Assisted Surgery; 7.2.2. Virtual Nursing Assistant; 7.2.3. Administrative Workflow Assistance; 7.2.4. Clinical Trials; 7.2.5. Diagnostics; 7.2.6. Others; 7.3. Market Analysis, Insights and Forecast – By End-user; 7.3.1. Hospitals & Clinics; 7.3.2. Pharmaceutical & Biotechnology Companies; 7.3.3. Contract Research Organization (CRO); 7.3.4. Others; 7.4. Market Analysis, Insights and Forecast – By Country/ Sub-region; 7.4.1. U.K.; 7.4.2. Germany; 7.4.3. France; 7.4.4. Scandinavia; 7.4.5. Rest of Europe
8. Asia Pacific Artificial Intelligence in Healthcare Analysis, Insights and Forecast, 2019-2032: 8.1. Market Analysis, Insights and Forecast – By Platform; 8.1.1. Solutions; 8.1.2. Services; 8.2. Market Analysis, Insights and Forecast – By Application; 8.2.1. Robot-Assisted Surgery; 8.2.2. Virtual Nursing Assistant; 8.2.3. Administrative Workflow Assistance; 8.2.4. Clinical Trials; 8.2.5. Diagnostics; 8.2.6. Others; 8.3. Market Analysis, Insights and Forecast – By End-user; 8.3.1. Hospitals & Clinics; 8.3.2. Pharmaceutical & Biotechnology Companies; 8.3.3. Contract Research Organization (CRO); 8.3.4. Others; 8.4. Market Analysis, Insights and Forecast – By Country/ Sub-region; 8.4.1. China; 8.4.2. Japan; 8.4.3. India; 8.4.4. Southeast Asia; 8.4.5. Rest of Asia Pacific
9. Latin America Artificial Intelligence in Healthcare Analysis, Insights and Forecast, 2019-2032: 9.1. Market Analysis, Insights and Forecast – By Platform; 9.1.1. Solutions; 9.1.2. Services; 9.2. Market Analysis, Insights and Forecast – By Application; 9.2.1. Robot-Assisted Surgery; 9.2.2. Virtual Nursing Assistant; 9.2.3. Administrative Workflow Assistance; 9.2.4. Clinical Trials; 9.2.5. Diagnostics; 9.2.6. Others; 9.3. Market Analysis, Insights and Forecast – By End-user; 9.3.1. Hospitals & Clinics; 9.3.2. Pharmaceutical & Biotechnology Companies; 9.3.3. Contract Research Organization (CRO); 9.3.4. Others; 9.4. Market Analysis, Insights and Forecast – By Country/ Sub-region; 9.4.1. Brazil; 9.4.2. Mexico; 9.4.3. Rest of Latin America
10. Middle East & Africa Artificial Intelligence in Healthcare Analysis, Insights and Forecast, 2019-2032: 10.1. Market Analysis, Insights and Forecast – By Platform; 10.1.1. Solutions; 10.1.2. Services; 10.2. Market Analysis, Insights and Forecast – By Application; 10.2.1. Robot-Assisted Surgery; 10.2.2. Virtual Nursing Assistant; 10.2.3. Administrative Workflow Assistance; 10.2.4. Clinical Trials; 10.2.5. Diagnostics; 10.2.6. Others; 10.3. Market Analysis, Insights and Forecast – By End-user; 10.3.1. Hospitals & Clinics; 10.3.2. Pharmaceutical & Biotechnology Companies; 10.3.3. Contract Research Organization (CRO); 10.3.4. Others; 10.4. Market Analysis, Insights and Forecast – By Country/ Sub-region; 10.4.1. GCC; 10.4.2. South Africa; 10.4.3. Rest of Middle East & Africa
11. Competitive Analysis: 11.1. Global Market Share Analysis (2023); 11.2. Profiles of Players Operating in the Market; 11.2.1. Amazon.com, Inc.; 11.2.1.1. Overview; 11.2.1.2. Products & Services; 11.2.1.3. SWOT Analysis; 11.2.1.4. Recent Developments; 11.2.1.5. Strategies; 11.2.1.6. Financials (Based on Availability); 11.2.2. Microsoft Corporation; 11.2.2.1. Overview; 11.2.2.2. Products & Services; 11.2.2.3. SWOT Analysis; 11.2.2.4. Recent Developments; 11.2.2.5. Strategies; 11.2.2.6. Financials (Based on Availability); 11.2.3. NVIDIA Corporation; 11.2.3.1. Overview; 11.2.3.2. Products & Services; 11.2.3.3. SWOT Analysis; 11.2.3.4. Recent Developments; 11.2.3.5. Strategies; 11.2.3.6. Financials (Based on Availability); 11.2.4. Alphabet Inc.; 11.2.4.1. Overview; 11.2.4.2. Products & Services; 11.2.4.3. SWOT Analysis; 11.2.4.4. Recent Developments; 11.2.4.5. Strategies; 11.2.4.6. Financials (Based on Availability); 11.2.5. Hewlett Packard Enterprise Company; 11.2.5.1. Overview; 11.2.5.2. Products & Services; 11.2.5.3. SWOT Analysis; 11.2.5.4. Recent Developments; 11.2.5.5. Strategies; 11.2.5.6. Financials (Based on Availability); 11.2.6. Intel Corporation; 11.2.6.1. Overview; 11.2.6.2. Products & Services; 11.2.6.3. SWOT Analysis; 11.2.6.4. Recent Developments; 11.2.6.5. Strategies; 11.2.6.6. Financials (Based on Availability); 11.2.7. Siemens AG; 11.2.7.1. Overview; 11.2.7.2. Products & Services; 11.2.7.3. SWOT Analysis; 11.2.7.4. Recent Developments; 11.2.7.5. Strategies; 11.2.7.6. Financials (Based on Availability); 11.2.8. General Electric Company; 11.2.8.1. Overview; 11.2.8.2. Products & Services; 11.2.8.3. SWOT Analysis; 11.2.8.4. Recent Developments; 11.2.8.5. Strategies; 11.2.8.6. Financials (Based on Availability); 11.2.9. Veradigm LLC; 11.2.9.1. Overview; 11.2.9.2. Products & Services; 11.2.9.3. SWOT Analysis; 11.2.9.4. Recent Developments; 11.2.9.5. Strategies; 11.2.9.6. Financials (Based on Availability); 11.2.10. UnitedHealth Group, (Optum Inc.); 11.2.10.1. Overview; 11.2.10.2. Products & Services; 11.2.10.3. SWOT Analysis; 11.2.10.4. Recent Developments; 11.2.10.5. Strategies; 11.2.10.6. Financials (Based on Availability); 12.